| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7262f4b18180bed86229f59cee26ccb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2c3d4b908392e2d4ccd2fc50880749a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a7ea77096697a9a2405730a41a878c |
| publicationDate |
2021-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113244205-A |
| titleOfInvention |
Treatment of Multiple Myeloma |
| abstract |
The present invention generally relates to the treatment of multiple myeloma. One embodiment of the present invention provides the use of trichostatin A (TSA) in the manufacture of a medicament for the treatment of multiple myeloma (MM) overexpressing at least one gene selected from The group consisting of CCNB1, TOP2A, KIF11 and WEE1, wherein trichostatin A is the sole inhibitor of said at least one gene in said drug; and wherein said drug is sufficient to reduce overexpressed said at least one gene expression of a gene. |
| priorityDate |
2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |